Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PGEN
#1850
Precigen, Inc. - Common Stock
6.9
4
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.48%
Monthly Change
+24.82%
6 month change
+90.14%
Year Change
+53.54%
Previous Close
7.1
9
Open
6.9
9
Low
6.9
2
High
7.0
0
Volume
1 087
Markets
US Stock Market
Healthcare
Biotechnology
PGEN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
205.66 M
206.93 M
252.19 M
248.92 M
294.04 M
353.93 M
358.04 M
Valuation ratios
Enterprise value
2.22 B
907.95 M
411.61 M
343.4 M
299.81 M
1.54 B
2.77 B
Price to earnings ratio
—
-7.89
10.57
-3.62
-2.38
-3.05
-7.03
Price to sales ratio
—
7.06
11.02
5 746.6
—
135.09
—
Price to cash flow ratio
—
-13.16
-4.56
-5.15
-4.4
-14.9
-22.37
Price to book ratio
—
6.83
2.35
2.91
7.79
62.56
20.58
Enterprise value to EBITDA ratio
28.13
9.64
20.39
-18.29
-18.73
-14.37
—
Profitability ratios
Return on assets %
-0.54
-0.26
0.13
-0.63
-0.87
-1.61
0.12
Return on equity %
-2.54
-0.86
0.22
-0.81
-3.28
-11.99
0.46
Return on invested capital %
90.63
157.21
20.96
-87.55
-118.51
-995.59
109.22
Gross margin %
100
100
100
100
—
100
100
Operating margin %
59.43
77.45
35.01
-42.4 K
—
-1 141.13
41.18
EBITDA margin %
76.41
90.7
75.01
-31.29 K
—
-1 108.1
43.19
Net margin %
-165.27
-88.73
105.23
-159.84 K
—
-2 588.21
36.51
Liquidity ratios
Quick ratio
3.27
4.14
1.5
—
—
2.83
3.89
Current ratio
3.54
4.52
1.5
2.99
4.76
3.09
4.58
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.27
0.31
0.09
0
0
0.06
0.36
Solvency ratios
Debt to assets ratio
0.55
0.51
0
—
—
0.6
0.55
Debt to equity ratio
2.55
1.7
0
—
—
4.46
2.15
Long term debt to total assets ratio
0.55
0.51
0.2
—
—
0.6
0.55
Long term debt to total equity ratio
2.56
1.71
0.34
—
—
4.46
2.15
Per share metrics
Operating cash flow per share
—
-0.28
-0.32
-0.27
-0.25
-0.28
-0.34
EBIT per share
—
0.41
0.05
-0.1
-0.08
-0.35
—
EBITDA per share
—
0.48
0.1
-0.08
-0.06
-0.34
—
Total debt per share
—
0.93
0.22
—
—
0.3
0.23
Cash per share
—
0.58
0.28
0.26
0.37
0.32
0.09
Net current asset value per share
—
0.79
0.59
0.28
0.38
0.37
0.32
Tangible book value per share
—
0.54
0.63
0.48
0.14
0.01
0.06
Working capital per share
—
0.62
0.2
0.19
0.3
0.25
0.25
Book value per share
—
0.54
0.63
0.48
0.14
0.07
0.11
News
Here's Why You Should Add ARQT Stock to Your Portfolio Now
Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program
Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen
SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis
5 Biotech Stocks Worth Adding to Your Portfolio Now
Here's Why You Should Add ACET Stock to Your Portfolio Now
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
Reasons Why Investors Should Consider Betting on PGEN Stock
Nuvectis Stock Surges Around 97% in 3 Months: Here's Why